The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Excessive Daytime Sleepiness Market Grow Between 2026 And 2030?
The excessive daytime sleepiness market has experienced robust growth in recent years. It is projected to expand from $5.39 billion in 2025 to $5.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. Historically, this growth has been driven by factors such as the increasing prevalence of sleep disorders, a rising awareness of the impacts of sleep health, the expansion of sleep clinic infrastructure, the availability of pharmacological wake-promoting agents, and the broadening of diagnostic sleep testing services.
The market for excessive daytime sleepiness is projected to experience substantial expansion in the coming years. This market is anticipated to reach $8.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the forecast period include a rising demand for tailored sleep treatment strategies, the increasing incorporation of digital therapeutics into sleep care, a wider embrace of remote patient monitoring, an expanding emphasis on proactive sleep healthcare, and greater investment in sleep medicine research. Key trends for the forecast period encompass the increasing uptake of wearable devices for sleep monitoring, the broader application of combination therapy methods, the growth of home-based management for sleep disorders, a heightened focus on early detection and screening initiatives, and improved integration of digital platforms for sleep health.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33109&type=smp
What Key Drivers Are Fueling The Growth Of The Excessive Daytime Sleepiness Market?
The growing incidence of obstructive sleep apnea (OSA) is projected to drive the expansion of the excessive daytime sleepiness (EDS) market moving forward. Obstructive sleep apnea is a sleep condition marked by repeated interruptions in breathing during sleep due to an upper airway blockage, leading to fragmented sleep and a reduction in sleep quality. The rise in obstructive sleep apnea cases is attributed to increasing obesity rates, which cause excess fat in the neck and throat area, narrowing the airway and resulting in breathing interruptions during sleep. Excessive daytime sleepiness is a prevalent and debilitating indicator of obstructive sleep apnea and frequently continues to affect a substantial portion of patients, thereby stimulating the demand for focused therapeutic and management solutions. For instance, in August 2026, according to the National Library of Medicine, a US-based medical library, it is anticipated that by 2050, approximately 76.6 million adults aged 30–69 in the United States will be impacted by obstructive sleep apnea. Consequently, the increasing prevalence of obstructive sleep apnea is propelling the growth of the excessive daytime sleepiness market.
How Is The Excessive Daytime Sleepiness Market Organized By Segment Classification?
The excessive daytime sleepiness market covered in this report is segmented –
1) By Treatment Type: Pharmacological Treatment; Behavioral Therapy; Continuous Positive Airway Pressure Therapy; Lifestyle Modification Programs; Combination Therapies
2) By Diagnosis Method: Polysomnography; Multiple Sleep Latency Test; Actigraphy; Clinical Evaluation; Questionnaire Based Assessments
3) By Type Of Disorder: Narcolepsy; Obstructive Sleep Apnea; Insomnia; Circadian Rhythm Disorders; Idiopathic Hypersomnia; Restless Legs Syndrome; Other Type Of Disorders
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospitals; Sleep Clinics; Ambulatory Surgical Centers; Home Care Settings
Subsegments:
1) By Pharmacological Treatment: Wake Promoting Medications; Central Nervous System Stimulant Medications; Dopamine Reuptake Inhibitor Medications; Histamine Receptor Modulating Medications
2) By Behavioral Therapy: Cognitive Behavioral Therapy For Sleep; Sleep Hygiene Education Programs; Stimulus Control Therapy; Sleep Restriction Therapy
3) By Continuous Positive Airway Pressure Therapy: Fixed Pressure Airway Therapy; Auto Adjusting Airway Therapy; Bilevel Airway Therapy; Adaptive Pressure Support Therapy
4) By Lifestyle Modification Programs: Sleep Schedule Regulation Programs; Diet And Nutrition Management Programs; Physical Activity And Exercise Programs; Stress Management And Relaxation Programs
5) By Combination Therapies: Medication And Behavioral Therapy Combinations; Airway Therapy And Lifestyle Modification Combinations; Medication And Airway Therapy Combinations; Integrated Multimodal Treatment Approaches
What Trends Are Influencing The Excessive Daytime Sleepiness Market?
Companies operating in the excessive daytime sleepiness market are actively pursuing the development of innovative solutions, such as central nervous system depressants, to enhance wakefulness and improve the quality of life for patients. A central nervous system depressant is a substance that reduces nervous system activity, leading to effects like sedation, calmness, or sleep. For example, in September 2025, Amneal Pharmaceuticals Inc., a US-based pharmaceutical company, received FDA approval for its sodium oxybate oral solution, which directly addresses excessive daytime sleepiness (EDS) in narcolepsy patients. This solution improves treatment continuity through virtual specialist consultations, remote prescription fulfillment, and expanded patient reach in underserved areas, aiming to broaden access, improve affordability, and align established pharmacotherapy with evolving digital and telehealth-driven care models for excessive daytime sleepiness.
Who Are The Industry Participants Involved In The Excessive Daytime Sleepiness Market?
Major companies operating in the excessive daytime sleepiness market are Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Cleveland Clinic, EisAI Co. Ltd, Jazz Pharmaceuticals plc., Emory Healthcare Inc., Alkermes plc., Fisher & Paykel Healthcare Corporation Limited, Harmony Biosciences Holdings Inc., Medanta, Axsome Therapeutics Inc., Compumedics Limited, BIOPROJET, Apnimed Inc., Nox Health Inc., Somnogen Canada Inc., Suven Life Sciences Limited, Theranexus, XWPharma, NLS Pharmaceutics AG.
Get The Full Excessive Daytime Sleepiness Market Report:
https://www.thebusinessresearchcompany.com/report/excessive-daytime-sleepiness-market-report
Which Geographic Region Dominates The Excessive Daytime Sleepiness Market?
North America was the largest region in the excessive daytime sleepiness market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the excessive daytime sleepiness market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Excessive Daytime Sleepiness Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33109&type=smp
Browse Through More Reports Similar to the Global Excessive Daytime Sleepiness Market 2026, By The Business Research Company
Insomnia Market Report 2026
https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report
Sleep Testing Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report
Sleep Monitoring Apps Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-monitoring-apps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model